Logo image of SNDA

SONIDA SENIOR LIVING INC (SNDA) Stock Fundamental Analysis

NYSE:SNDA - US1404752032 - Common Stock

26.18 USD
-0.13 (-0.49%)
Last: 8/27/2025, 8:18:20 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SNDA. SNDA was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of SNDA have multiple concerns. SNDA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SNDA has reported negative net income.
In the past year SNDA had a positive cash flow from operations.
In the past 5 years SNDA reported 4 times negative net income.
In the past 5 years SNDA reported 4 times negative operating cash flow.
SNDA Yearly Net Income VS EBIT VS OCF VS FCFSNDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

The Return On Assets of SNDA (-4.59%) is worse than 68.32% of its industry peers.
With a Return On Equity value of -36.12%, SNDA is not doing good in the industry: 70.30% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.59%
ROE -36.12%
ROIC N/A
ROA(3y)-4.67%
ROA(5y)-8.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNDA Yearly ROA, ROE, ROICSNDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SNDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SNDA Yearly Profit, Operating, Gross MarginsSNDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

SNDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SNDA has been increased compared to 1 year ago.
The number of shares outstanding for SNDA has been increased compared to 5 years ago.
The debt/assets ratio for SNDA has been reduced compared to a year ago.
SNDA Yearly Shares OutstandingSNDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SNDA Yearly Total Debt VS Total AssetsSNDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SNDA has an Altman-Z score of 0.02. This is a bad value and indicates that SNDA is not financially healthy and even has some risk of bankruptcy.
SNDA has a Altman-Z score of 0.02. This is in the lower half of the industry: SNDA underperforms 78.22% of its industry peers.
A Debt/Equity ratio of 6.12 is on the high side and indicates that SNDA has dependencies on debt financing.
SNDA's Debt to Equity ratio of 6.12 is on the low side compared to the rest of the industry. SNDA is outperformed by 81.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.12
Debt/FCF N/A
Altman-Z 0.02
ROIC/WACCN/A
WACC7.88%
SNDA Yearly LT Debt VS Equity VS FCFSNDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.85 indicates that SNDA may have some problems paying its short term obligations.
With a Current ratio value of 0.85, SNDA is not doing good in the industry: 79.21% of the companies in the same industry are doing better.
SNDA has a Quick Ratio of 0.85. This is a bad value and indicates that SNDA is not financially healthy enough and could expect problems in meeting its short term obligations.
SNDA's Quick ratio of 0.85 is on the low side compared to the rest of the industry. SNDA is outperformed by 72.28% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85
SNDA Yearly Current Assets VS Current LiabilitesSNDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

SNDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.60%, which is quite impressive.
SNDA shows a small growth in Revenue. In the last year, the Revenue has grown by 4.96%.
SNDA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.41% yearly.
EPS 1Y (TTM)57.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.4%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y9.04%
Revenue growth 5Y-7.41%
Sales Q2Q%18.19%

3.2 Future

Based on estimates for the next years, SNDA will show a small growth in Earnings Per Share. The EPS will grow by 5.04% on average per year.
SNDA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.85% yearly.
EPS Next Y-3.35%
EPS Next 2Y2.51%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue Next Year27.22%
Revenue Next 2Y16.54%
Revenue Next 3Y12.85%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SNDA Yearly Revenue VS EstimatesSNDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
SNDA Yearly EPS VS EstimatesSNDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNDA. In the last year negative earnings were reported.
Also next year SNDA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNDA Price Earnings VS Forward Price EarningsSNDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

SNDA's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.12
SNDA Per share dataSNDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.51%
EPS Next 3Y5.04%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONIDA SENIOR LIVING INC

NYSE:SNDA (8/27/2025, 8:18:20 PM)

26.18

-0.13 (-0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-11 2025-08-11/bmo
Earnings (Next)11-11 2025-11-11
Inst Owners81.57%
Inst Owner Change0.82%
Ins Owners19.06%
Ins Owner Change2.84%
Market Cap492.71M
Analysts43.33
Price Target26.52 (1.3%)
Short Float %2.09%
Short Ratio13.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.21
Dividend Growth(5Y)N/A
DP-14.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.21%
Min EPS beat(2)20.54%
Max EPS beat(2)79.89%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.4
P/FCF N/A
P/OCF 39.13
P/B 4.56
P/tB 5.84
EV/EBITDA 32.12
EPS(TTM)-2.4
EYN/A
EPS(NY)-2.87
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)0.67
OCFY2.56%
SpS18.71
BVpS5.74
TBVpS4.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.59%
ROE -36.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.67%
ROA(5y)-8.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 6.12
Debt/FCF N/A
Debt/EBITDA 18.33
Cap/Depr 59.55%
Cap/Sales 8.69%
Interest Coverage N/A
Cash Conversion 34.97%
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z 0.02
F-Score4
WACC7.88%
ROIC/WACCN/A
Cap/Depr(3y)55.33%
Cap/Depr(5y)43.9%
Cap/Sales(3y)8.53%
Cap/Sales(5y)6.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.4%
EPS Next Y-3.35%
EPS Next 2Y2.51%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue 1Y (TTM)4.96%
Revenue growth 3Y9.04%
Revenue growth 5Y-7.41%
Sales Q2Q%18.19%
Revenue Next Year27.22%
Revenue Next 2Y16.54%
Revenue Next 3Y12.85%
Revenue Next 5YN/A
EBIT growth 1Y-37.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year656.42%
EBIT Next 3Y110.17%
EBIT Next 5YN/A
FCF growth 1Y-5.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y150.41%
OCF growth 3YN/A
OCF growth 5YN/A